NCT05359861 2026-03-18
Trial of Atezolizumab and Bevacizumab With SRF388 or Placebo in Patients With Hepatocellular Carcinoma
Coherus Oncology, Inc.
Phase 2 Completed
Coherus Oncology, Inc.
Hoffmann-La Roche
Federation Francophone de Cancerologie Digestive
Lokon Pharma AB
M.D. Anderson Cancer Center